Extendicare Inc. (TSE:EXE - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$10.75 and traded as high as C$13.04. Extendicare shares last traded at C$12.99, with a volume of 193,086 shares.
Wall Street Analysts Forecast Growth
EXE has been the subject of several recent research reports. BMO Capital Markets increased their price target on Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd. Cormark raised Extendicare to a "moderate buy" rating in a research report on Wednesday, February 19th. Finally, TD Securities raised their price objective on Extendicare from C$10.50 to C$13.00 and gave the company a "hold" rating in a research report on Monday, March 3rd.
Check Out Our Latest Stock Analysis on Extendicare
Extendicare Trading Down 0.4 %
The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The firm has a market capitalization of C$1.11 billion, a P/E ratio of 16.91 and a beta of 1.26. The business's 50-day moving average is C$12.46 and its 200 day moving average is C$10.83.
Extendicare Increases Dividend
The business also recently declared a monthly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, May 15th will be paid a $0.042 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 3.80%. The ex-dividend date is Wednesday, April 30th. This is an increase from Extendicare's previous monthly dividend of $0.04. Extendicare's payout ratio is 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
